Azor and Agitation - a phase IV clinical study of FDA data

Summary:

Agitation is reported as a side effect among people who take Azor (amlodipine besylate; olmesartan medoxomil), especially for people who are female, 50-59 old, also take Metformin, and have Depression.

The phase IV clinical study analyzes which people have Agitation when taking Azor. It is created by eHealthMe based on reports of 3,584 people who have side effects when taking Azor from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Agitation?

Agitation (state of anxiety or nervous excitement) is found to be associated with 2,284 drugs and 3,315 conditions by eHealthMe. Check the latest studies of Agitation.

On Aug, 02, 2026

3,584 people reported to have side effects when taking Azor.
Among them, 11 people (0.31%) have Agitation.

Among these 11 people:

What is the gender of people who have Agitation when taking Azor? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Agitation when taking Azor? *

What are other drugs people take besides Azor? *

What are other side effects people have besides Agitation? *

Fatigue (feeling of tiredness): 6 people, 54.55%
Dizziness: 4 people, 36.36%
Hyperhidrosis (abnormally increased sweating): 3 people, 27.27%
Feeling Abnormal: 3 people, 27.27%
Hypotension (abnormally low blood pressure): 3 people, 27.27%
Confusional State: 3 people, 27.27%
Abnormal Behavior: 3 people, 27.27%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 18.18%
Pain: 2 people, 18.18%
Pain In Extremity: 2 people, 18.18%

What are the existing conditions these people have? *

Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 18.18%
High Blood Cholesterol: 2 people, 18.18%
Diabetes: 2 people, 18.18%
Depression: 2 people, 18.18%
Weight Decreased: 1 person, 9.09%
Roseolovirus Test Positive: 1 person, 9.09%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 1 person, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Menopause (end of monthly cycles in women): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and have Agitation?

- Check whether Agitation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azor:

Azor (3,922 reports)

Agitation treatments and more:

Agitation (142,108 reports)

How severe was Agitation and when was it recovered:

Agitation in Azor

Expand to all the drugs that have ingredients of amlodipine besylate; olmesartan medoxomil:

Agitation and drugs with ingredients of amlodipine besylate; olmesartan medoxomil

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agitation:

Agitation (2,284 drugs)

Browse all the conditions that are associated with Agitation:

Agitation (3,315 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil (the active ingredients of Azor) and Azor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.